Sign in

    Jane Lindemann

    Research Analyst at private investor

    No verifiable information about Jane Lindemann working as an analyst at Private Investor or holding an equivalent financial analyst position could be found in public records or on LinkedIn. There are no accessible performance metrics, specific companies covered, professional achievements, career timeline, or credentials associated with this individual in authoritative finance or analyst reporting platforms. At this time, a comprehensive professional profile matching these criteria does not exist.

    Jane Lindemann's questions to IMMUCELL CORP /DE/ (ICCC) leadership

    Jane Lindemann's questions to IMMUCELL CORP /DE/ (ICCC) leadership • Q3 2024

    Question

    The private investor asked for the approximate number of shares sold through the at-the-market (ATM) offering and whether the company anticipates needing to continue using the facility.

    Answer

    The executive stated that shares outstanding increased by approximately 1.1 million and referred to the 10-Q for exact figures. He explained that while future use of the ATM is at the Board's discretion, the company's improved cash position has reduced the immediate need to sell more shares, especially at current price levels.

    Ask Fintool Equity Research AI